HOME       CME/CE INFORMATION       PROGRAM DIRECTORS       NEWSLETTER ARCHIVE       EDIT PROFILE       RECOMMEND TO A COLLEAGUE
  VOLUME 3 – ISSUE 4
Featured Cases: Infantile hemangioma: Update on Therapy
After participating in this activity the participant will demonstrate the ability to:

Describe current controversies in management of infantile hemangiomas
Identify potential side effects of propranolol and prednisolone therapy,
Recognize factors that place infants at higher risk for side effects from treatment with propranolol.

This audio activity has been developed for clinicians caring for patients with dermatologic issues related to infantile hemangiomas. You can also read the companion newsletter
. In this edition Dr. Puttgen will offer current clinical perspective to the use of propranolol and prednisolone therapy for the treatment of infantile hemangiomas, with the discussion of some typical case scenarios.

Unlabeled/Unapproved Uses
The author has indicated her presentation today will include references to the unlabeled or unapproved uses of propranolol, prednisolone/prednisone in the treatment of infantile hemangioma.
Katherine B. Puttgen, MD
Assistant Professor
Department of Dermatology
Division of Pediatric Dermatology
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Faculty Disclosures
Katherine B. Puttgen, MD discloses that she has no financial relationship with commercial supporters.

Release Date
January 10, 2012
Expiration Date
January 9, 2014
Next Issue
February 14, 2012
Buddy Cohen, MD, MBA
Professor, Dermatology Chief, Department of Dermatology
The Johns Hopkins Medical Institutions
Baltimore, MD
Susan Matra Rabizadeh, MD, MBA
Department of Dermatology
Cedars-Sinai Medical Group
Beverly Hills, CA
  Mark Lebwohl, MD
Chairman, Department of Dermatology
Mount Sinai School of Medicine
New York, NY
  Elizabeth Sloand, PhD, CRNP
Assistant Professor
Johns Hopkins University
School of Nursing
Baltimore, MD
accreditation statements
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Centers Commission on Accreditation.

The Institute for Johns Hopkins Nursing and the American Nurses Credentialing Center do not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.


credit designations
Physicians
Podcast: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Nurses
Podcast: This 0.5 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Podcast carries a maximum of 0.5 contact hours or a total of 3 contact hours for the six podcasts in this program.


Launch Date
This program launched on October 11, 2011 and is published bi-monthly; activities expire 2 years from the date of publication.
Post-test
To take the post-test for eMedicalDermatology Review you will need to visit the Johns Hopkins University School of Medicine's CME website or the Institute for Johns Hopkins Nursing. If you have already registered for another Hopkins CME program at these sites, simply enter the requested information when prompted. Otherwise, complete the registration form to begin the testing process. A passing grade of 70% or higher on the post test/evaluation is required to receive CME/CNE credit.


faculty disclosure
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Johns Hopkins University School of Medicine to require the disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. The Program Directors reported the following:
Susan Matra Rabizadeh, MD, MBA discloses that she serves on the advisory board and is receiving an honorarium from Allergan.
Mark Lebwohl, MD has disclosed that he has received grants for clinical research from Can-Fite Biopharma and Clinuvel. He also disclosed that he has worked as a consultant for and receiving honorarium from Abgenomics, Allos, Amgen, Astellas, DermaGenoma, DermiPsor, Ethicon, Genentech, GlaxoSmithKline-Stiefel, Glenmark Pharmaceuticals, HelixBioMedix, Janssen Ortho Biotech, LEO Pharmaceuticals, Novartis, Nycomed, Onset Therapeutics, Pfizer, Valeant Pharmaceuticals.
No other planners have indicated that they have any financial interests or relationships with a commercial entity.
Guest Author Disclosures

Statement of Responsibility
The Johns Hopkins University School of Medicine take responsibility for the content, quality and scientific integrity of this CME activity.

intended audience
This activity has been developed for the dermatologist, nurses, dermasurgeon, dermatopathologist, pediatric dermatologist, Immunodermatologist, wound care specialist and allied healthcare providers.


Confidentiality Disclaimer for CME Conference Attendees
I certify that I am attending a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am attending in this capacity, I may be exposed to “protected health information,” as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the “Privacy Regulations”). Protected health information is information about a person's health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.

“The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only.”

For CME Questions, please contact the CME Office at (410) 955-2959 or e-mail cmenet@jhmi.edu.

Johns Hopkins University School of Medicine
Office of Continuing Medical Education
Turner 20/720 Rutland Avenue
Baltimore, Maryland 21205-2195

Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)

Updated 4/09


internet cme policy
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public.

Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based program. Your information will never be given to anyone outside the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.


Disclaimer Statement
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

hardware & software requirements
PC: Internet Explorer (v6 or greater), or Firefox
MAC: Safari
If you want to now listen to the eMedicalDermatology Review podcast, just click on the button above. This will open your Internet browser to play the podcast by streaming the media via the web.

Please note: This podcast file is large so please be patient while the content downloads.
Save the podcast to your computer. Once saved you can manage and play the file like any song or music using your music software (iTunes, Windows Media, Real Player, etc.). You can also transfer the podcast file to your iPod, MP3 player and listen while on-the-go.
Like any RSS subscription,
when you subscribe to
this Review you will automatically receive each new edition, downloaded to your hard drive as soon as it becomes available. You may manage and play the downloaded podcast file like any song or audio file by using your music software (iTunes, Windows Media, Real Player, etc.). You can also transfer the podcast file to your iPod, MP3 player to listen while on-the-go.
COMPLETE THE
POST-TEST


Step 1. Click on the appropriate link below. This will take you to the post-test.

Step 2. If you have participated in a Johns Hopkins on-line course, login. Otherwise, please register.

Step 3. Complete the post-test and course evaluation.

Step 4. Print out your certificate.
»Download the podcast transcript
»Go to the companion newsletter
»Learn more about podcasting
 
Help other clinicians find solutions to their medical dermatologic challenges. Forward a link to the eMedicalDermatology Review website to a colleague.
  UV Therapy In Age of Biologics
 
© 2012 JHUSOM, IJHN and eMedicalDermatology Review

Presented by JHUSOM and IJHN in collaboration with DKBmed